We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new business division created by Johnson & Johnson (J&J) is the brand manufacturer’s first step toward competing in the generic drug market, according to a spokeswoman for a J&J subsidiary.